Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Ann Surg Oncol. 2022 Aug;29(8):5241-5242.
doi: 10.1245/s10434-022-11622-0.
1 Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. a.v.akkooi@nki.nl.
2 Mayo Clinic, Rochester, MN, USA.
3 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
4 Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
5 Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
6 Azienda di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Italy.
7 Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
8 Massachusetts General Hospital, Boston, MA, USA.
9 Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
10 Royal Prince Alfred Hospital, Sydney, NSW, Australia.
11 Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
12 Northside Hospital Cancer Institute, Atlanta, GA, USA.
13 AC Camargo Cancer Center, São Paulo, Brazil.
14 The Angeles Clinic, Cedars Sinai Medical Center, Los Angeles, CA, USA.
15 Erasmus MC - Cancer Institute, Rotterdam, The Netherlands.
16 Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
17 Oregon Health and Science University, Portland, Oregon, USA.
18 Royal Marsden NHS Foundation Trust, London, UK.
19 Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
20 Royal North Shore Hospital, St. Leonards, NSW, Australia.
21 The Mater Hospital, North Sydney, NSW, Australia.
22 Winship Cancer Institute, Emory University, Atlanta, GA, USA.
23 Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
24 Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.